Japanese Gastric Cancer Association Task Force for Research Promotion: Clinical utility of 18F-fluoro-2-deoxyglucose positron emission tomography in gastric cancer. A systematic review of the literature

Gastric Cancer

Volumn 14, Issue 1, 2011, Pages 13-21

  Shimada, Hideaki ^a,b   Okazumi, Shinichi ^a   Koyama, Masamichi ^c   Murakami, Koji ^d  

^a TOHO UNIVERSITY   (Japan)

^b Society of Japanese Gastric Cancer Task Force for Research Promotion   (Japan)

^c CANCER INSTITUTE   (Japan)

^d KEIO UNIVERSITY   (Japan)

Author keywords

Gastric cancer; PET; Systematic review

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE TRANSPORTER 1;

ARTICLE; CANCER RECURRENCE; CANCER SCREENING; CANCER STAGING; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISTANT METASTASIS; DRUG TUMOR LEVEL; FALSE NEGATIVE RESULT; HEALTH CARE ORGANIZATION; HISTOLOGY; HUMAN; INFECTION RATE; JAPAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; STOMACH CANCER; SYSTEMATIC REVIEW; TREATMENT RESPONSE;

EARLY DETECTION OF CANCER; FLUORODEOXYGLUCOSE F18; GASTRIC MUCOSA; GLUCOSE TRANSPORTER TYPE 1; HUMANS; LYMPHATIC METASTASIS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 79953026785     PISSN: 14363291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10120-011-0017-5     Document Type: Article

References (52)

1. K Kamimura S Fujita R Nishii H Wakamatsu S Nagamachi T Yano, et al. 2007 An analysis of the physiological FDG uptake in the stomach with the water gastric distention method Eur J Nucl Med Mol Imaging 34 1815 1818 17546453 10.1007/s00259-007-0477-3 (Pubitemid 47599056)
2. H Koga M Sasaki Y Kuwabara K Hiraka M Nakagawa K Abe, et al. 2003 An analysis of the physiological FDG uptake pattern in the stomach Ann Nucl Med 17 733 738 14971621 10.1007/BF02984984 1:CAS:528:DC%2BD2cXjtVahtbg%3D (Pubitemid 38196949)
3. K Kamimura S Nagamachi H Wakamatsu S Fujita R Nishii Y Umemura, et al. 2009 Role of gastric distention with additional water in differentiating locally advanced gastric carcinomas from physiological uptake in the stomach on 18F-fluoro-2-deoxy-d-glucose PET Nucl Med Commun 30 431 439 19352209 10.1097/MNM.0b013e3283299a2f
4. TA Heusner S Hahn ME Hamami UH Kim R Baumeister M Forsting, et al. 2009 Gastrointestinal 18F-FDG accumulation on PET without a corresponding CT abnormality is not an early indicator of cancer development Eur Radiol 19 2171 2179 19415294 10.1007/s00330-009-1405-7
5. H Takahashi K Ukawa N Ohkawa K Kato Y Hayashi K Yoshimoto, et al. 2009 Significance of (18)F-2-deoxy-2-fluoro-glucose accumulation in the stomach on positron emission tomography Ann Nucl Med 23 391 397 19399579 10.1007/s12149-009-0255-3
6. Z Zhu F Li Y Mao W Cheng X Cheng Y Dang 2008 Improving evaluation of primary gastric malignancies by distending the stomach with milk immediately before 18F-FDG PET scanning J Nucl Med Technol 36 25 29 18287193 10.2967/jnmt.107.044081 (Pubitemid 351520589)
7. T Kawamura T Kusakabe T Sugino K Watanabe T Fukuda A Nashimoto, et al. 2001 Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival Cancer 92 634 641 11505409 10.1002/1097-0142(20010801)92:3<634::AID-CNCR1364>3.0.CO;2-X 1:CAS:528:DC%2BD3MXmsVyjtLc%3D (Pubitemid 32735200)
8. A Yamada K Oguchi M Fukushima Y Imai M Kadoya 2006 Evaluation of 2-deoxy-2-[18F] fluoro-d-glucose positron emission tomography in gastric carcinoma: relation to histological subtypes, depth of tumor invasion, and glucose transporter-1 expression Ann Nucl Med 20 597 604 17294670 10.1007/BF02984657 1:CAS:528:DC%2BD2sXhvFyktrw%3D (Pubitemid 44954052)
9. H Alakus M Batur M Schmidt U Drebber SE Baldus D Vallböhmer, et al. 2010 Variable 18F-fluorodeoxyglucose uptake in gastric cancer is associated with different levels of GLUT-1 expression Nucl Med Commun 31 532 538 20220543 1:CAS:528:DC%2BC3cXns12jtrw%3D
10. DA Podoloff DW Ball E Ben-Josef AB Benson 3rd SJ Cohen RE Coleman, et al. 2009 NCCN task force: clinical utility of PET in a variety of tumor types J Natl Compr Canc Netw. 7 Suppl 2 S1 S26 19555588 (Review)
11. BE Hillner BA Siegel AF Shields D Liu IF Gareen E Hunt, et al. 2008 Relationship between cancer type and impact of PET and PET/CT on intended management: findings of the National Oncologic PET Registry J Nucl Med 49 1928 1935 18997054 10.2967/jnumed.108.056713
12. A Stahl K Ott WA Weber K Becker T Link JR Siewert, et al. 2003 FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings Eur J Nucl Med Mol Imaging 30 288 295 12552348 10.1007/s00259-002-1029-5 1:CAS:528:DC%2BD3sXms1Cmsw%3D%3D (Pubitemid 36686849)
13. FP Esteves DM Schuster RK Halkar 2006 Gastrointestinal tract malignancies and positron emission tomography: an overview Semin Nucl Med 36 169 181 16517238 10.1053/j.semnuclmed.2005.12.002 Review (Pubitemid 43320452)
14. SJ Rosenbaum H Stergar G Antoch P Veit A Bockisch H Kühl 2006 Staging and follow-up of gastrointestinal tumors with PET/CT Abdom Imaging 31 25 35 16333707 10.1007/s00261-005-0031-3 1:STN:280:DC%2BD28%2FhsFGjug%3D%3D Review
15. YJ Sohn JS Jang SR Choi HC Kwon GJ Jung MC Kim, et al. 2009 Early detection of recurrence after endoscopic treatment for early gastric cancer Scand J Gastroenterol 44 1109 1114 19593687 10.1080/00365520903121701
16. T Terauchi T Murano H Daisaki D Kanou H Shoda R Kakinuma, et al. 2008 Evaluation of whole-body cancer screening using 18F-2-deoxy-2-fluoro-d-glucose positron emission tomography: a preliminary report Ann Nucl Med 22 379 385 18600415 10.1007/s12149-008-0130-7 (Pubitemid 351938513)
17. H Tsujimoto H Sugasawa S Ono T Ichikura J Yamamoto K Hase 2010 Has the accuracy of preoperative diagnosis improved in cases of early-stage gastric cancer? World J Surg 34 1840 1846 20407771 10.1007/s00268-010-0587-0
18. J Chen JH Cheong MJ Yun J Kim JS Lim WJ Hyung, et al. 2005 Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography Cancer 103 2383 2390 15856477 10.1002/cncr.21074 (Pubitemid 40686585)
19. RM Kwee TC Kwee 2009 Imaging in assessing lymph node status in gastric cancer Gastric Cancer 12 6 22 19390927 10.1007/s10120-008-0492-5 1:CAS:528:DC%2BD1MXosleisL0%3D Review
20. K Mukai Y Ishida K Okajima H Isozaki T Morimoto S Nishiyama 2006 Usefulness of preoperative FDG-PET for detection of gastric cancer Gastric Cancer 9 192 196 16952037 10.1007/s10120-006-0374-7 (Pubitemid 44426892)
21. E Mochiki H Kuwano H Katoh T Asao N Oriuchi K Endo 2004 Evaluation of 18F-2-deoxy-2-fluoro-d-glucose positron emission tomography for gastric cancer World J Surg 28 247 253 14961197 10.1007/s00268-003-7191-5 (Pubitemid 38375523)
22. T Lerut P Flamen N Ectors E Van Cutsem M Peeters M Hiele, et al. 2000 Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: a prospective study based on primary surgery with extensive lymphadenectomy Ann Surg 232 743 752 11088069 10.1097/00000658-200012000-00003 1:STN:280:DC%2BD3M%2FltVyntA%3D%3D
23. SK Kim KW Kang JS Lee HK Kim HJ Chang JY Choi, et al. 2006 Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer Eur J Nucl Med Mol Imaging 33 148 155 16228236 10.1007/s00259-005-1887-8 (Pubitemid 43152881)
24. QM Yang T Kawamura H Itoh E Bando M Nemoto S Akamoto, et al. 2008 Is PET-CT suitable for predicting lymph node status for gastric cancer? Hepatogastroenterology 55 782 785 18613454 (Pubitemid 351741548)
25. M Yun JS Lim SH Noh WJ Hyung JH Cheong JK Bong, et al. 2005 Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT J Nucl Med 46 1582 1588 16204706 (Pubitemid 46211580)
26. Kim EY, Lee WJ, Choi D, Lee SJ, Choi JY, Kim BT, et al. The value of PET/CT for preoperative staging of advanced gastric cancer: comparison with contrast-enhanced CT. Eur J Radiology 2010 (Epub ahead of print).
27. T Yoshioka K Yamaguchi K Kubota T Saginoya T Yamazaki T Ido, et al. 2003 Evaluation of 18F-FDG PET in patients with advanced, metastatic, or recurrent gastric cancer J Nucl Med 44 690 699 12732669 1:CAS:528:DC%2BD3sXkt1KisL8%3D (Pubitemid 39655202)
28. JS Lim MJ Kim MJ Yun YT Oh JH Kim HS Hwang, et al. 2006 Comparison of CT and 18F-FDG PET for detecting peritoneal metastasis on the preoperative evaluation for gastric carcinoma Korean J Radiol 7 249 256 17143028 10.3348/kjr.2006.7.4.249 (Pubitemid 44905083)
29. A Turlakow HW Yeung AS Salmon HA Macapinlac SM Larson 2003 Peritoneal carcinomatosis: role of (18)F-FDG PET J Nucl Med 44 1407 1412 12960184 (Pubitemid 39663352)
30. QM Yang E Bando T Kawamura G Tsukiyama M Nemoto Y Yonemura, et al. 2006 The diagnostic value of PET-CT for peritoneal dissemination of abdominal malignancies Jpn J Cancer Chemother 33 1817 1821 1:CAS:528: DC%2BD2sXkt1Wnsg%3D%3D
31. M Yun HS Choi E Yoo JK Bong YH Ryu JD Lee 2005 The role of gastric distention in differentiating recurrent tumor from physiologic uptake in the remnant stomach on 18F-FDG PET J Nucl Med 46 953 957 15937305 (Pubitemid 43733509)
32. T De Potter P Flamen E Van Cutsem F Penninckx L Filez G Bormans, et al. 2002 Whole-body PET with FDG for the diagnosis of recurrent gastric cancer Eur J Nucl Med Mol Imaging 29 525 529 11914891 10.1007/s00259-001-0743-8
33. L Sun XH Su YS Guan WM Pan ZM Luo JH Wei, et al. 2008 Clinical role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in post-operative follow up of gastric cancer: initial results World J Gastroenterol 14 4627 4632 18698676 10.3748/wjg.14.4627
34. SH Sim YJ Kim DY Oh SH Lee DW Kim WJ Kang, et al. 2009 The role of PET/CT in detection of gastric cancer recurrence BMC Cancer 9 73 19250554 10.1186/1471-2407-9-73
35. MJ Park WJ Lee HK Lim KW Park JY Choi BT Kim 2009 Detecting recurrence of gastric cancer: the value of FDG PET/CT Abdom Imaging 34 441 447 18543017 10.1007/s00261-008-9424-4
36. Bilici A, Ustaalioglu BB, Seker M, Kefeli U, Canpolat N, Tekinsoy B, et al. The role of (18) F-FDG PET/CT in the assessment of suspected recurrent gastric cancer after initial surgical resection: can the results of FDG PET/CT influence patients' treatment decision making? Eur J Nucl Med Mol Imaging. 2010 (Epub ahead of print).
37. Y Nakamoto K Togashi T Kaneta H Fukuda K Nakajima K Kitajima, et al. 2009 Clinical value of whole-body FDG-PET for recurrent gastric cancer: a multicenter study Jpn J Clin Oncol 39 297 302 19269991 10.1093/jjco/hyp010
38. T Suga Y Nakamoto T Saga T Higashi T Hara K Ishizu, et al. 2010 Prevalence of positive FDG-PET findings in patients with high CEA levels Ann Nucl Med 24 433 439 20544325 10.1007/s12149-010-0387-5
39. WL Wong RJ Chambers 2008 Role of PET/PET CT in the staging and restaging of thoracic oesophageal cancer and gastro-oesophageal cancer: a literature review Abdom Imaging 33 183 190 17619927 10.1007/s00261-007-9241-1 (Review) (Pubitemid 351514663)
40. SM Lee SH Kim JM Lee SA Im YJ Bang WH Kim, et al. 2009 Usefulness of CT volumetry for primary gastric lesions in predicting pathologic response to neoadjuvant chemotherapy in advanced gastric cancer Abdom Imaging 34 430 440 18546037 10.1007/s00261-008-9420-8
41. SA Suttie AE Welch KG Park 2009 Positron emission tomography for monitoring response to neoadjuvant therapy in patients with oesophageal and gastro-oesophageal junction carcinoma Eur J Surg Oncol 35 1019 1029 19232881 1:STN:280:DC%2BD1Mnhs1KgtA%3D%3D (Review)
42. F Di Fabio C Pinto FL Rojas Llimpe S Fanti P Castellucci C Longobardi, et al. 2007 The predictive value of 18F-FDG-PET early evaluation in patients with metastatic gastric adenocarcinoma treated with chemotherapy plus cetuximab Gastric Cancer 10 221 227 18095077 10.1007/s10120-007-0438-3 1:CAS:528:DC%2BD2sXhsVGgt7rI (Pubitemid 350308171)
43. K Ott U Fink K Becker A Stahl HJ Dittler R Busch, et al. 2003 Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: results of a prospective trial J Clin Oncol 21 4604 4610 14673049 10.1200/JCO.2003.06.574 1:CAS:528:DC%2BD2cXpsVWqurg%3D (Pubitemid 46594034)
44. K Ott K Herrmann F Lordick H Wieder WA Weber K Becker, et al. 2008 Early metabolic response evaluation by fluorine-18 fluorodeoxyglucose positron emission tomography allows in vivo testing of chemosensitivity in gastric cancer: long-term results of a prospective study Clin Cancer Res 14 2012 2018 18381939 10.1158/1078-0432.CCR-07-0934 1:CAS:528:DC%2BD1cXkt1akur0%3D (Pubitemid 351551110)
45. D Vallböhmer AH Hölscher PM Schneider M Schmidt M Dietlein E Bollschweiler, et al. 2010 [18F]-Fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemotherapy in gastric cancer J Surg Oncol 102 135 140 20648583 10.1002/jso.21592
46. AE Dassen DJ Lips CJ Hoekstra JF Pruijt K Bosscha 2009 FDG-PET has no definite role in preoperative imaging in gastric cancer Eur J Surg Oncol. 35 449 455 19147324 1:STN:280:DC%2BD1M3ltlOjsw%3D%3D (Review)
47. R Minamimoto M Senda K Uno S Jinnouchi T Iinuma K Ito, et al. 2007 Performance profile of FDG-PET and PET/CT for cancer screening on the basis of a Japanese Nationwide Survey Ann Nucl Med 21 481 498 18030580 10.1007/s12149-007-0061-8 (Pubitemid 350165651)
48. S Nishizawa S Kojima S Teramukai M Inubushi H Kodama Y Maeda, et al. 2009 Prospective evaluation of whole-body cancer screening with multiple modalities including [18F]fluorodeoxyglucose positron emission tomography in a healthy population: a preliminary report J Clin Oncol 27 1767 1773 19255324 10.1200/JCO.2008.18.2238
49. O Israel N Yefremov R Bar-Shalom O Kagana A Frenkel Z Keidar, et al. 2005 PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance J Nucl Med 46 758 762 15872347
50. H Shoda Y Kakugawa D Saito T Kozu T Terauchi H Daisaki, et al. 2007 Evaluation of 18F-2-deoxy-2-fluoro-glucose positron emission tomography for gastric cancer screening in asymptomatic individuals undergoing endoscopy Br J Cancer 97 1493 1498 18040274 10.1038/sj.bjc.6604062 1:STN:280: DC%2BD2sjgtlaisA%3D%3D (Pubitemid 350175848)
51. JW Lee KW Kang JC Paeng SM Lee SJ Jang JK Chung, et al. 2009 Cancer screening using 18F-FDG PET/CT in Korean asymptomatic volunteers: a preliminary report Ann Nucl Med 23 685 691 19662344 10.1007/s12149-009-0291-z
52. H Hur SH Kim W Kim KY Song CH Park HM Jeon 2010 The efficacy of preoperative PET/CT for prediction of curability in surgery for locally advanced gastric carcinoma World J Surg Oncol. 8 86 20932345 10.1186/1477-7819-8-86